Navigation Links
Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients
Date:4/23/2009

t-experienced patients with HCV genotype 1. In this study, low doses of ritonavir were used for metabolic inhibition to enhance the levels of SCH 900518 within the body and reduce the frequency of SCH 900518 dosing (BID vs. TID).

In the study, SCH 900518 administered as monotherapy exhibited potent antiviral activity, achieving 4.0-4.5 log10 decreases in viral load (HCV RNA) from baseline at day 8. SCH 900518 was well tolerated, with no drug related serious adverse events. Pharmacokinetic and pharmacodynamic modeling from this study was used to design the ongoing Phase IIa dose-finding study of SCH 900518 with ritonavir in combination with PEGINTRON and REBETOL. This study, known as NEXT-1, explores SCH 900518 in 200 mg, 400 mg or 600 mg once daily (QD) doses with low-dose ritonavir (100 mg) in combination with PEGINTRON and REBETOL (with and without a 4-week P/R lead-in period) in treatment-naive patients with HCV genotype 1.

About the HCV SPRINT-1 Study

In this Phase II study, known as HCV SPRINT-1 (HCV Serine Protease Inhibitor Therapy-1), boceprevir (800 mg TID) was evaluated in three treatment regimens: 4 weeks of PEGINTRON (1.5 mcg/kg once weekly) and REBETOL (800-1400 mg daily based on patient weight) therapy followed by the addition of boceprevir to the combination for 24 or 44 weeks (totaling 28 or 48 weeks of treatment), boceprevir in combination with PEGINTRON and REBETOL at the doses described above for 28 or 48 weeks, and, in Part II of the study, boceprevir in combination with PEGINTRON and low-dose REBETOL (400-1000 mg daily based on patient weight) for 48 weeks. In Part I of the study, the boceprevir regimens were compared to a control of PEGINTRON (1.5 mcg/kg once weekly) and REBETOL (800-1400 mg daily based on patient weight) alone for 48 weeks (an approved treatment regimen). In Part II of the study, boceprevir in combination with PEGINTRON and low-dose REBETOL for 48 weeks was compared t
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
2. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
3. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
4. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
5. Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
6. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
7. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
8. Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
9. Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
10. The Anatomy of Clinical Trials: Greys Season Finale Leaves Public in the Dark About the Myths and Realities
11. Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015 A new report from Kalorama ... – Chile , ... top targets for IVD firms.  The healthcare research firm said ... IVD strategies for the Latin American continent with a population ... distributed supply operations. However, the country,s regional economic clout does ...
(Date:3/27/2015)... March 27, 2015 Zimmer Holdings, Inc. (NYSE and ... system for trauma patients. Available in both ... ® External Fixation System from Zimmer is a modular ...   The XtraFix System allows surgeons to ... external fixation process, resulting in saved time, costs and overall ...
(Date:3/27/2015)... 2015 CHINA AID, ... Care, Rehabilitation Medicine and Healthcare, second to none in ... be held at Shanghai New International Expo Center on ... Implementation Suggestions on Encouraging Private Capital to Participate in ... jointly issued by the Ministry of Civil Affairs of ...
Breaking Medicine Technology:Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4Zimmer Debuts New Modular External Fixation System 2Zimmer Debuts New Modular External Fixation System 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 4CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 5CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 6
(Date:3/28/2015)... March 28, 2015 One in three ... to research presented today at the American Orthopaedic Society ... study examined the long term success of surgery for ... examined survey data from 242 patients who underwent ACL ... P. Roe, MBBS, FRACS, from North Sydney Orthopaedic and ...
(Date:3/28/2015)... 2015 Andrew Hawley of Vintage Rock Posters ... concert posters. The Who and the Doors played together at ... 1968. According to Hawley, “The Who toured the United States ... college campuses. Perhaps the most famous Who poster was a ... the Doors on August 2, 1968 at the Singer Bowl ...
(Date:3/28/2015)... Designers and Professionals of FCPX plugins ... from Pixel Film Studios. , “Scratches 5K allows users ... Final Cut Pro X” Said Christina Austin, CEO of ... an effective tool for any FCPX editor.” , Scratch ... grunge overlays. Simply drag title layers into the FCPX ...
(Date:3/27/2015)... The Monogamy Method - a new ... Jason Rogers has just been released to the public ... surrounding the course's launch has caught the attention of ... review of the new program. , "Many women report ... suddenly start pulling away or expressing interest in other ...
(Date:3/27/2015)... March 27, 2015 First Choice Emergency ... The new facility is located 12665 W Lake Houston Pkwy, ... resident of Summerwood, I look forward to delivering the highest ... Sowell, Facility Medical Director of First Choice Emergency Room Summerwood. ... Room made a donation to Summer Creek High School at ...
Breaking Medicine News(10 mins):Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:The Monogamy Method - Review Of Samantha Sanderson & Jason Rogers' Relationship Program Released 2Health News:First Choice Emergency Room Opens New Facility in Houston, Texas 2
... singing reduced the blood pressure of a 76-year-old ... to total knee replacement surgery for osteoarthritis (OA). ... interventions, the woman,s blood pressure dropped dramatically when ... in the April issue of Arthritis Care ...
... News) -- Obese patients are twice as likely as ... a general anesthetic, a new study has found. ... to develop such problems, according to the report. ... that occurred among patients who received general anesthesia in ...
... , NEW YORK (March 29, 2011) -- Bariatric surgery is ... moderately and severely obese patients. These findings and others were ... for Type 2 Diabetes, hosted by NewYork-Presbyterian Hospital and Weill ... effectiveness is central to the larger issue of access to ...
... -- Problem gambling is more common among American adults than ... the Research Institute on Addictions at the University of Buffalo, ... gambling is rare. The researchers analyzed two national surveys ... of 2,274 younger people, aged 14 to 21 -- to ...
... bodies is only indirectly connected to their body mass index ... according to recent research. The most powerful influence ... important others view them, the study suggests. On the flip ... inner workings of their body or how their bodies ...
... at castle walls is one way to attack an ... vulnerable. Researchers at Cedars-Sinai,s Maxine Dunitz Neurosurgical Institute ... to target important mechanisms inside the most challenging breast ... approach effective in attacking malignant brain tumor targets. ...
Cached Medicine News:Health News:Case study reports singing lowers patient's blood pressure prior to surgery 2Health News:Obesity Could Raise Risks of General Anesthesia 2Health News:Bariatric surgery highly cost-effective treatment for type 2 diabetes in the obese 2Health News:Bariatric surgery highly cost-effective treatment for type 2 diabetes in the obese 3Health News:Bariatric surgery highly cost-effective treatment for type 2 diabetes in the obese 4Health News:Younger, Poorer People More Prone to Problem Gambling 2Health News:Women's body image based more on others' opinions than their own weight 2Health News:Women's body image based more on others' opinions than their own weight 3Health News:Women's body image based more on others' opinions than their own weight 4Health News:New 'nanodrug' breaks down barriers to attack breast cancer cells from the inside out 2Health News:New 'nanodrug' breaks down barriers to attack breast cancer cells from the inside out 3
Curved with catch....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Medicine Products: